Chinese Researchers Finds Tarceva/Iressa Combo Reverses Alzheimer's
This article was originally published in PharmAsia News
Executive Summary
A team of Chinese scientists working with U.S. counterparts concluded after a study that two drugs for treating non small-cell lung cancer, OSI Pharms'a Tarceva (erlotinib) and AstraZeneca's Iressa (gefitinib) are able to treat Alzheimer's disease in rats and fruit flies.